본문 바로가기
KERD
논문KCI 등재

淸肝解酒湯이 TGF-β1 유도성 간섬유화에 미치는 영향

The Effect of Chungganhaeju-tang on TGF-β1-induced Hepatic Fibrosis

1

조회

0

다운로드

9

인용

0

참고문헌

주제분류한의학

초록

Abstract

Objectives: The aim of this study is to characterize the effect of Chungganhaeju-tang on TGF-β1-induced hepatic fibrosis. Materials and Methods: mRNA and protein expression levels of TGF-β1 in Chungganhaeju-tang treated HepG2 cells were compared to untreated cells using quantitative RT-PCR and ELISA assay, respectively. mRNA expression levels of the TGF-β1 signaling pathway genes (TβR-1, TβR-II, Smad2, Smad3, Smad4, and PAI-1) and fibrosis-associated genes (CTGF, fibronectin, and collagen type 1α) were evaluated by quantitative RT-PCR. The effect of Chungganhaeju-tang on cell proliferation of T3891 human fibroblast was evaluated using [3H]Thymidine Incorporation Assay. Results: Inhibition of TGF-β1 mRNA expression and protein production was observed with treatment of Chungganhaeju-tang and seen to be dose and time dependent. Whereas TGF-β1-mediated induction of PAI-1 was suppressed with treatment of Chungganhaeju-tang, expression of the TGF-β1 signaling pathway genes such as TβR-1, TβR-II, Smad2, Smad3, and Smad4 was not affected. With treatment of Chungganhaeju-tang, inhibition of TGF-β1-induced cell proliferation of T3891 human fibroblast was observed, as well as abrogation of TGF-β1-mediated transcriptional up-regulation of CTGF, fibronectin, and collagen type Iα. Conclusion: This study strongly suggests that the liver cirrhosis-suppressive activity of Chungganhaeju-tang may be derived at least in part from its inhibitory effect on TGF-β1 functions, such as blockade of TGF-β1 stimulation of fibroblast cell proliferation and fibrosis-related gene expression as well as expression of TGF-β1 itself.

참고문헌 (28)

  1. "한국의 사회지표 2003", pp.25~8 (2004), 통계청
  2. "간경변증의 원인적 분류와 형태학적 특징", 24(4), pp.412~22 (1990)
  3. "1990년대 간경변증의 원인, 합병증, 사망원인의 변화에 관한 고찰", 6(3), pp.328~39 (2000)
  4. "간경변증 환자에서 CTP점수와 MELD점수에 따른 사망률 분석", 9(2), pp.98~106 (2003)
  5. "알코올성 간질환의 새로운 치료법과 전망", 9(1), pp.36~45 (2003)
  6. "알코올성 간질환의 일반적 치료", 9(1), pp.16~26 (2003)
  7. "淸肝解酒湯이 알코올대사 및 손상간에 미치는 영향", 21(1), pp.68~76 (2000)
  8. "淸肝解酒湯이 알코올성 지방간에 미치는 영향에 대한 임상적 연구", 22(4), pp.107~13 (2001)
  9. "淸肝解酒湯이 alcohol 대사관련 유전자 및 apoptosis에 미치는 영향", 24(1), pp.123~33 (2003)
  10. "淸肝解酒湯이 에탄올 매개성 cytokine발현에 미치는 영향", 24(1), pp.190~201 (2003)
  11. "淸肝解酒湯이 인체간세포의 Glutathione 생성에 미치는 영향", 25(1), pp.81~91 (2004)
  12. "淸肝解酒湯이 kupffer cell의 NFκB 활성화 및 세포사멸에 미치는 영향", 25(1), pp.59~70 (2004)
  13. "Transforming Growth Factor βs 연구의 역사와 미래", 3(4), pp.17~ (1996)
  14. "Mechanism of Disease Transforming growth factor β in tissue fibrosis The New England Journal of Medicine", pp.1286~92 (1994)
  15. "대한약전 및 대한약전외 한약규격주해", pp.58~ (1998), 한국메디칼인덱스사
  16. "2002 사망원인통계연보", pp.26~33 (2003), 통계청
  17. "간 섬유화에서 간 성상세포의 역할", pp.177~83 (2003)
  18. "만성간질환의 미세구조-간섬유조직증식과 간유동의 성상세포", 8(3), pp.343~53 (2002)
  19. "On the origin of hepatic fibrosis", 128, pp.1212~1214 (2004)
  20. "The cellular basis of hepatic fibrosis The New England Journal of Medicine"
  21. "Hepatic expression of mature transforming growth factor β1 in transgenic mice results in multiple tissue leisions", 92, pp.2572~6 (1995)
  22. "Regulatory mechanisms for transforming growth factor β as an autocrine inhibitor in human hepatocellular carcinoma:Implications for roles of Smads in its growth", 32(2), pp.218~27 (2000)
  23. "n-Butyrate induces plasminogen activator inhibitor type 1 messenger RNA in Cultured HepG2 cells", 23(4), pp.866~71 (1996)
  24. "Molecular regulation of hepatic fibrosis an integrated cellular response to tissue injury The Journal of Biological Chemistry", 275(4), pp.2247~50 (2000)
  25. "down-regulation by cAMP", 13, pp.1774~86 (1999)
  26. "Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis", 282, pp.933~42 (2002)
  27. "茵蔯이 TGF-β1 유도성 간섬유화에 미치는 영향", 22(3), pp.141~55 (2001)
  28. "茵蔯淸肝湯이 TGF-β1 매개성 간섬유화에 미치는 영향", 24(2), pp.1~11 (2003)

관련 논문AI추천

이 간행물의 다른 논문 (6건)